EFFECTS OF DRAMA- AND ANİMATİON-SUPPORTED FİRST AİD EDUCATİON İN PRESCHOOL CHİLDREN

September 25, 2026 updated by: Sinem Öztürkler, Kocaeli University

THE EFFECT OF A DRAMA- AND ANİMATİON-SUPPORTED FİRST AİD EDUCATİON PROGRAM ON FİRST AİD AWARENESS, KNOWLEDGE, AND SKİLLS İN PRESCHOOL CHİLDREN

This study aims to evaluate the effect of a drama- and animation-supported first aid education program on first aid awareness, knowledge, and skills in preschool children. The program is designed according to the developmental characteristics of preschool children and uses age-appropriate drama activities, animations, scenarios, visual materials, puppets, and hands-on activities. The study will examine whether participation in this educational program improves children's ability to recognize situations requiring first aid, distinguish safe from unsafe behaviors, seek help from an appropriate adult, and demonstrate age-appropriate first aid responses.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study is a single-group, pretest-posttest quasi-experimental study designed to evaluate the effectiveness of a developmentally appropriate first aid education program for preschool children. The study will include preschool children aged 57-71 months who meet the eligibility criteria and whose parents or legal guardians provide written informed consent. Children's voluntary participation will also be respected throughout the study.

The intervention consists of the Children's First Aid - Drama- and Animation-Supported Education (ÇİDA) Program. The program is delivered over five weeks and includes structured educational sessions based on active participation, drama, role-play, animation, storytelling, puppets, visual scenarios, games, demonstrations, and hands-on activities. Each educational session lasts approximately 20-25 minutes.

The educational content focuses on recognizing situations that may require first aid, maintaining personal safety, seeking help from an appropriate adult, and demonstrating age-appropriate safe responses. The sessions address helping behavior, safety before providing help, bleeding, falls and injuries, suspected fractures or sprains, burns, foreign bodies in the eye, ear, or nose, and choking or breathing difficulties. The final week includes review activities and scenario-based practice to reinforce previously learned behaviors.

Children's first aid-related awareness, knowledge, and skills will be assessed before and after the educational program. Assessment will include age-appropriate scenario-based questions and structured observation of children's responses and first aid-related behaviors during simulated situations. The evaluation focuses on whether children can recognize a potentially dangerous or first aid-related situation, avoid unsafe actions, select an appropriate response, and seek help from an adult.

The primary objective is to determine whether participation in the ÇİDA Program improves preschool children's first aid awareness, knowledge, and skills from pre-intervention to post-intervention. The study also aims to provide evidence regarding the feasibility of using developmentally appropriate, interactive, and experiential teaching methods for first aid education in preschool settings.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
50

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

4 years to 5 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Children aged 57-71 months. Enrolled in a participating preschool classroom in İzmit, Kocaeli, Türkiye. Written informed consent provided by a parent or legal guardian. Willingness of the child to participate in the age-appropriate study activities and assessments.

Exclusion Criteria:

Children outside the specified age range. Children who are not enrolled in one of the participating preschool classrooms. Lack of written informed consent from a parent or legal guardian. Children who decline to participate in the study activities or assessments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: ÇİDA Education Group

Participants in this arm will receive the Children's First Aid - Drama- and Animation-Supported Education (ÇİDA) Program. The program will be delivered over five weeks using developmentally appropriate drama, animation, role-play, puppets, visual scenarios, games, demonstrations, and hands-on activities. First aid awareness, knowledge, and skills will be assessed before and after the intervention.
Behavioral: Drama- and Animation-Supported First Aid Education (ÇİDA) Program

The ÇİDA Program is a five-week, developmentally appropriate first aid education program for preschool children. It includes drama, animation, storytelling, puppets, role-play, visual scenarios, games, demonstrations, and hands-on activities. The program focuses on recognizing situations requiring first aid, maintaining personal safety, avoiding unsafe interventions, seeking help from an appropriate adult, and demonstrating age-appropriate responses to bleeding, falls and injuries, suspected fractures or sprains, burns, foreign bodies, and choking situations.
No Intervention: Control Group

Participants in this arm will not receive the ÇİDA education program during the comparison period. They will undergo the same pre-intervention and post-intervention assessments as the intervention group. After completion of the post-intervention assessments, the control group will be offered the ÇİDA education program.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change in First Aid Awareness and Knowledge Score
Time Frame: Baseline and immediately after completion of the 5-week education program

First aid awareness and knowledge will be assessed using the 24-item First Aid Evaluation Form developed for preschool children. Each item is scored from 0 to 2, with a total score ranging from 0 to 48. Higher scores indicate greater first aid awareness and knowledge.
Baseline and immediately after completion of the 5-week education program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Kocaeli University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2027

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 15, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 25, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 25, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 2, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 2, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 25, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2026/526
  • 226K830 (Other Grant/Funding Number: The Scientific and Technological Research Council of Türkiye (TÜBİTAK))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be publicly shared because the study involves preschool children and the data are subject to confidentiality and ethical restrictions. De-identified aggregate study results will be reported in scientific publications and presentations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings